Drug intelligence / Profile preview

rhein lysinate

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral
01

Overview

**Rhein lysinate** is a water-soluble derivative of rhein, created by forming a lysine salt of the anthraquinone compound rhein. Rhein itself is a bioactive molecule found in rhubarb root and used in traditional Chinese medicine. Rhein lysinate has been developed to improve rhein’s poor water solubility and bioavailability, thus making it more suitable for pharmaceutical use. Mechanistically, rhein lysinate exerts anti-inflammatory effects primarily via inhibition of both TNF-α and IL-6, as well as blockade of NF-κB signaling. It also shows antioxidant properties and can prevent and treat diabetic complications by improving insulin sensitivity, reducing oxidative stress, and protecting kidney function in diabetic nephropathy models. Preclinical studies indicate it may also protect against age-associated inflammation and oxidative stress in neurodegeneration and improve metabolic disorders such as obesity-induced cognitive impairment.

Brand names
rhein lysinate
Other names
rhein lysinateRHL
02

Targets

IL-6 (Interleukin 6)NF-κBPPARG (Peroxisome proliferator-activated receptor gamma)TNFA (Tumor necrosis factor alpha (soluble))SIRT1 (NAD-dependent protein deacetylase sirtuin-1)

Beyond the preview

Go deeper on rhein lysinate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rhein lysinate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call